Randomized comparison of 3 limus agent-eluting stents for the reduction of coronary restenosis

Trial Profile

Randomized comparison of 3 limus agent-eluting stents for the reduction of coronary restenosis

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Jan 2013

At a glance

  • Drugs Probucol (Primary) ; Sirolimus (Primary) ; Zotarolimus
  • Indications Coronary artery disease; Coronary artery restenosis; Myocardial ischaemia
  • Focus Registrational; Therapeutic Use
  • Acronyms ISAR-TEST-2; ISAR-TEST2
  • Most Recent Events

    • 15 Mar 2010 Two-year results were reported at the 59th Annual Scientific Session of the American College of Cardiology.
    • 16 Jun 2008 Patient numbers amended from 1006 to 1007.
    • 26 Jul 2007 Status changed from in progress to completed
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top